Associated Papers
Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.
Salani F et al.
Esmo Open, 2025
Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status.
Orozco-Castaño C et al.
Journal of the Egyptian National Cancer Institute, 2025
Functional annotation of the Hippo pathway somatic mutations in human cancers.
Han H et al.
Nature Communications, 2024
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors.
Chai R et al.
Npj Precision Oncology, 2024
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Williams EA et al.
Neuro-oncology, 2023
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine population.
Rosenberg S et al.
Molecular Oncology, 2023
Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis.
Oishi N et al.
Scientific Reports, 2023
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
Chen JL et al.
Annual Review of Genomics and Human Genetics, 2022
Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single-cell level.
Nakamura IT et al.
Cancer Science, 2021
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
Quetel L et al.
Molecular Oncology, 2020
CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.
Xu J et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2020
Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene.
Evans DG et al.
The Laryngoscope, 2019
Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient.
Miller CA et al.
Cold Spring Harbor Molecular Case Studies, 2018
Genetic landscape of sporadic vestibular schwannoma.
Håvik AL et al.
Journal of Neurosurgery, 2018
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
Boyd C et al.
Clinical Genetics, 2008
The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM et al.
Molecular and Cellular Biology, 2002